# A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

> **NCT02791269** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 24 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT02791269
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02791269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02791269, "A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02791269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*